INNOVIVA, INC. Increase (Decrease) in Deferred Charges
INNOVIVA, INC. (INVA) reported Increase (Decrease) in Deferred Charges of $5.00 thousand for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2015-11-05
- INNOVIVA, INC. increase (decrease) in deferred charges for the quarter ending 2015-09-30 was $2.00K.
- INNOVIVA, INC. increase (decrease) in deferred charges for the quarter ending 2015-06-30 was -$13.00K.
- INNOVIVA, INC. increase (decrease) in deferred charges for the quarter ending 2015-03-31 was $16.00K.
- INNOVIVA, INC. increase (decrease) in deferred charges for the quarter ending 2014-12-31 was -$51.00K.
- INNOVIVA, INC. increase (decrease) in deferred charges for fiscal 2014 was -$275.00K, a 191.97% decline from fiscal 2013.
- INNOVIVA, INC. increase (decrease) in deferred charges for fiscal 2013 was $299.00K, a 59.97% decline from fiscal 2012.
- INNOVIVA, INC. increase (decrease) in deferred charges for fiscal 2012 was $747.00K.
- INNOVIVA, INC. increase (decrease) in deferred charges for fiscal 2011 was -$2.43M.
| Period end | Increase (Decrease) in Deferred Charges 3 month | Increase (Decrease) in Deferred Charges 6 month | Increase (Decrease) in Deferred Charges 9 month | Increase (Decrease) in Deferred Charges 12 month |
|---|---|---|---|---|
| 2015-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$11.00K derived: sum of 2 quarters · filed 2015-11-05 | $5.00K 10-Q · filed 2015-11-05 | -$46.00K derived: sum of 4 quarters · filed 2015-11-05 |
| 2015-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $3.00K 10-Q · filed 2015-08-06 | -$48.00K derived: sum of 3 quarters · filed 2015-08-06 | -$89.00K derived: sum of 4 quarters · filed 2015-11-05 |
| 2015-03-31 | $16.00K 10-Q · filed 2015-05-08 | -$35.00K derived: sum of 2 quarters · filed 2015-05-08 | -$76.00K derived: sum of 3 quarters · filed 2015-11-05 | -$143.00K derived: sum of 4 quarters · filed 2015-11-05 |
| 2014-12-31 | -$51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$92.00K derived: sum of 2 quarters · filed 2015-11-05 | -$159.00K derived: sum of 3 quarters · filed 2015-11-05 | -$275.00K 10-K · filed 2015-02-27 |
| 2014-09-30 | -$41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$108.00K derived: sum of 2 quarters · filed 2015-11-05 | -$224.00K 10-Q · filed 2015-11-05 | -$341.00K derived: sum of 4 quarters · filed 2015-11-05 |
| 2014-06-30 | -$67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$183.00K 10-Q · filed 2015-08-06 | -$300.00K derived: sum of 3 quarters · filed 2015-08-06 | -$260.00K derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-03-31 | -$116.00K 10-Q · filed 2015-05-08 | -$233.00K derived: sum of 2 quarters · filed 2015-05-08 | -$193.00K derived: sum of 3 quarters · filed 2015-05-08 | -$19.00K derived: sum of 4 quarters · filed 2015-05-08 |
| 2013-12-31 | -$117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$77.00K derived: sum of 2 quarters · filed 2015-02-27 | $97.00K derived: sum of 3 quarters · filed 2015-02-27 | $299.00K 10-K · filed 2015-02-27 |
| 2013-09-30 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $214.00K derived: sum of 2 quarters · filed 2014-11-04 | $416.00K 10-Q · filed 2014-11-04 | $617.00K derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $174.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $376.00K 10-Q · filed 2014-08-07 | $577.00K derived: sum of 3 quarters · filed 2015-02-27 | $779.00K derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $202.00K 10-Q · filed 2014-05-07 | $403.00K derived: sum of 2 quarters · filed 2015-02-27 | $605.00K derived: sum of 3 quarters · filed 2015-02-27 | $806.00K derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $201.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $403.00K derived: sum of 2 quarters · filed 2015-02-27 | $604.00K derived: sum of 3 quarters · filed 2015-02-27 | $747.00K 10-K · filed 2015-02-27 |
| 2012-09-30 | $202.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | $403.00K derived: sum of 2 quarters · filed 2013-11-01 | $546.00K 10-Q · filed 2013-11-01 | $453.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | $201.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $344.00K 10-Q · filed 2013-08-01 | $251.00K derived: sum of 3 quarters · filed 2014-03-03 | -$153.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $143.00K 10-Q · filed 2013-05-01 | $50.00K derived: sum of 2 quarters · filed 2014-03-03 | -$354.00K derived: sum of 3 quarters · filed 2014-03-03 | -$1.51M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | -$93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$497.00K derived: sum of 2 quarters · filed 2014-03-03 | -$1.65M derived: sum of 3 quarters · filed 2014-03-03 | -$2.43M 10-K · filed 2014-03-03 |
| 2011-09-30 | -$404.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | -$1.56M derived: sum of 2 quarters · filed 2012-10-31 | -$2.34M 10-Q · filed 2012-10-31 | -$2.15M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-06-30 | -$1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | -$1.93M 10-Q · filed 2012-08-01 | -$1.74M derived: sum of 3 quarters · filed 2013-02-26 | -$2.45M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-03-31 | -$776.00K 10-Q · filed 2012-05-02 | -$585.00K derived: sum of 2 quarters · filed 2013-02-26 | -$1.29M derived: sum of 3 quarters · filed 2013-02-26 | |
| 2010-12-31 | $191.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$515.00K derived: sum of 2 quarters · filed 2013-02-26 | -$1.45M 10-K · filed 2013-02-26 | |
| 2010-09-30 | -$706.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$1.64M 10-Q · filed 2011-11-02 | ||
| 2010-06-30 | -$931.00K 10-Q · filed 2011-08-03 | |||
| 2009-12-31 | $709.00K 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |